• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病系列第 4 部分:识别、管理和预防加重。

Chronic Obstructive Pulmonary Disease Series Part 4: Identifying, Managing, and Preventing Exacerbations.

机构信息

Midwestern University College of Pharmacy Glendale, Glendale, Arizona.

出版信息

Sr Care Pharm. 2023 Sep 1;38(9):361-369. doi: 10.4140/TCP.n.2023.361.

DOI:10.4140/TCP.n.2023.361
PMID:37612845
Abstract

Chronic obstructive pulmonary disease (COPD) remains a leading cause of death in the United States, with exacerbations significantly contributing to overall morbidity, mortality, and health care costs. The purpose of this review is to discuss the recognition, treatment, and prevention of COPD exacerbations, with an emphasis on the role that pharmacists can have of ensuring appropriate treatment of acute exacerbations and preventing future exacerbations.

摘要

慢性阻塞性肺疾病(COPD)仍然是美国的主要死亡原因,其急性加重显著导致了整体发病率、死亡率和医疗保健成本。本文的目的是讨论 COPD 急性加重的识别、治疗和预防,重点介绍药师在确保急性加重症的适当治疗和预防未来加重方面的作用。

相似文献

1
Chronic Obstructive Pulmonary Disease Series Part 4: Identifying, Managing, and Preventing Exacerbations.慢性阻塞性肺疾病系列第 4 部分:识别、管理和预防加重。
Sr Care Pharm. 2023 Sep 1;38(9):361-369. doi: 10.4140/TCP.n.2023.361.
2
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.美国慢性阻塞性肺病加重住院后启动三联疗法的提示:PRIMUS 研究分析。
J Manag Care Spec Pharm. 2022 Dec;28(12):1366-1377. doi: 10.18553/jmcp.2022.28.12.1366.
3
Early identification of exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者病情加重的早期识别
J Prim Care Community Health. 2013 Jan;4(1):75-80. doi: 10.1177/2150131912443827. Epub 2012 Apr 18.
4
Recent Advances in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重的管理新进展。
Med Clin North Am. 2020 Jul;104(4):615-630. doi: 10.1016/j.mcna.2020.02.003.
5
COPD management costs according to the frequency of COPD exacerbations in UK primary care.根据英国初级保健中 COPD 加重的频率来管理 COPD 的成本。
Int J Chron Obstruct Pulmon Dis. 2014;9:65-73. doi: 10.2147/COPD.S54417. Epub 2014 Jan 9.
6
COPD exacerbations.慢性阻塞性肺疾病急性加重。
Am J Nurs. 2013 Feb;113(2):34-43; quiz 44. doi: 10.1097/01.NAJ.0000426688.96330.60.
7
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
8
Management of chronic obstructive pulmonary disease: A review focusing on exacerbations.慢性阻塞性肺疾病的管理:以急性加重为重点的综述。
Am J Health Syst Pharm. 2020 Feb 7;77(4):259-268. doi: 10.1093/ajhp/zxz306.
9
White paper on expanding the role of pharmacists in chronic obstructive pulmonary disease: American Pharmacists Association Foundation.《关于扩大药师在慢性阻塞性肺疾病中的作用的白皮书:美国药剂师协会基金会》
J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):203-11. doi: 10.1331/JAPhA.2011.11513.
10
Prediction and prevention of exacerbations and mortality in patients with COPD.慢性阻塞性肺疾病患者急性加重和死亡的预测与预防
Expert Rev Respir Med. 2016 Jul;10(7):739-53. doi: 10.1080/17476348.2016.1185371. Epub 2016 May 20.

引用本文的文献

1
Risk factors and predictive model for weaning failure in elderly patients with chronic obstructive pulmonary disease and type II respiratory failure.慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭老年患者撤机失败的危险因素及预测模型
Am J Transl Res. 2025 Jul 15;17(7):5485-5492. doi: 10.62347/KAAK3231. eCollection 2025.